MabCure Generates 10 Monoclonal Antibodies Against Prostate Cancer
Biotechnology company MabCure Inc has generated a panel of 10 novel monoclonal antibodies against prostate cancer.
Read MoreSearch Results for: prostate cancer
Study: Prostate Cancer Screening Improves Quality of Life
Posted by Clinical Lab Products | Oct 27, 2010 | Cancer, Miscellaneous |
Men treated for prostate cancer who were diagnosed after the start of routine screening had a significantly reduced risk of the disease spreading to other parts of the body within 10 years of treatment.
Read MoreBlood Test Accurately Predicts Death from Prostate Cancer Up to 25 Years in Advance
Posted by Clinical Lab Products | Sep 16, 2010 | Cancer, Miscellaneous |
A blood test at the age of 60 can accurately predict the risk that a man will die from prostate cancer within the next 25 years, according to researchers at Memorial Sloan-Kettering Cancer Center, in New York, and Lund University, in Sweden.
Read MoreScientists Develop Antibody to Detect Common Malignant Tissue Changes in Prostate Cancer
Posted by Clinical Lab Products | Jul 1, 2010 | Biochemicals & Chemical Reagents, Cancer, Prostate, Tissue Processing |
Researchers have developed a highly specific assay for the detection of ERG, a protein associated with tumor formations which is present in more than half of all prostate cancers.
Read MoreGenetic Markers Could Predict Prostate Cancer in Younger Men
Posted by Clinical Lab Products | Jun 9, 2010 | Cancer, Miscellaneous |
Researchers believe that genetics and traditional screening methods could play a role in predicting the risk of prostate cancer in younger men.
Read More